Matthew A. Ladda
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Addressing topical corticosteroid phobia in atopic dermatitis: The role of the pharmacist.
Journal: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
Published: April 19, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis.
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis.
Journal: Journal of cutaneous medicine and surgery
Published: August 08, 2020
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study.
Journal: Journal of cutaneous medicine and surgery
Published: May 23, 2020
Dose optimization of brodalumab in moderate-to-severe plaque psoriasis: A case report.
Journal: SAGE open medical case reports
Published: February 26, 2020
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: October 28, 2019
Off-label Uses of Topical Pimecrolimus.
Journal: Journal of cutaneous medicine and surgery
Published: May 05, 2019
Mohs Micrographic Surgery: Development of the Technique.
Journal: Journal of cutaneous medicine and surgery
Published: March 08, 2019
The Father of Medicine on Dermatology.
Journal: Journal of cutaneous medicine and surgery
Published: March 08, 2019
Ambulatory Medication Reconciliation in Dialysis Patients: Benefits and Community Practitioners' Perspectives.
Journal: The Canadian journal of hospital pharmacy
Published: January 05, 2018
The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.
Journal: Advances in chronic kidney disease
Published: September 04, 2015
Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species-inducing mechanism.
Journal: Pharmacology research & perspectives
Published: September 26, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026